Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
Clinical trial NCT00910000 · TERMINATED
Trial details
- NCT number
- NCT00910000
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.